Compounds > dalteparin

dalteparin and darexaban

dalteparin has been researched along with darexaban in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Funatsu, T; Iwatsuki, Y; Kaku, S; Kawasaki, T; Moritani, Y; Sato, T; Shigenaga, T; Suzuki, M1
Fuji, T; Nakamura, M; Takeuchi, M1
Agnelli, G; Eriksson, BI; Gallus, AS; Kashiwa, M; Lassen, MR; Prins, MH; Renfurm, RW; Turpie, AG1

Trials

2 trial(s) available for dalteparin and darexaban

ArticleYear
Darexaban for the prevention of venous thromboembolism in Asian patients undergoing orthopedic surgery: results from 2 randomized, placebo-controlled, double-blind studies.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2014, Volume: 20, Issue:2

    Topics: Adult; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Asian People; Azepines; Benzamides; Double-Blind Method; Drug Administration Schedule; Enoxaparin; Female; Humans; Male; Orthopedic Procedures; Risk Assessment; Risk Factors; Venous Thromboembolism; Young Adult

2014
Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3).
    Thrombosis and haemostasis, 2014, Volume: 111, Issue:2

    Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Australia; Azepines; Benzamides; Brazil; Canada; Double-Blind Method; Drug Administration Schedule; Elective Surgical Procedures; Enoxaparin; Europe; Female; Hemorrhage; Humans; India; Israel; Logistic Models; Male; Middle Aged; Odds Ratio; Phlebography; Risk Factors; South Africa; Time Factors; Treatment Outcome; United States; Venous Thromboembolism

2014

Other Studies

1 other study(ies) available for dalteparin and darexaban

ArticleYear
Biochemical and pharmacological profile of darexaban, an oral direct factor Xa inhibitor.
    European journal of pharmacology, 2011, Dec-30, Volume: 673, Issue:1-3

    Topics: Administration, Oral; Animals; Anticoagulants; Azepines; Benzamides; Bleeding Time; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Enoxaparin; Factor Xa Inhibitors; Glucuronides; Humans; Macaca fascicularis; Male; Mice; Mice, Inbred ICR; Prothrombin Time; Rabbits; Rats; Rats, Sprague-Dawley; Thrombosis; Venous Thrombosis; Warfarin

2011